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Figure IVA-D. IHC stainings in PSCC; S, stroma; T, tumor. (A) Nuclear β-catenin expression 
(arrowheads). (B) Nuclear p53 expression. (C) Cytoplasmic iNOS expression. (D) Stromal 
versican expression. 
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5.2.4. Versican (IV) 
 
In the tumor surroundings, there was immunoreactivity for versican in the blood vessel walls 
and in the peritumoral connective tissue. In carcinoma, strong stromal versican expression 
was graded according to median percentage (10%). It was high in 59 (50%) (Figure IVD), 
but low in 59 (50%) primary tumors. Cytoplasmic versican staining was present in the 
carcinoma cells in 9 (8%) tumors. Intracellular versican accumulation was more common in 
association with high strong stromal versican expression, though this association was 
statistically insignificantly. Of the 14 local lymph node metastases, in only one case was 
strong stromal versican expression graded low (<10%), while in the remaining 13 cases, the 
grade was high (≥10%). Strong stromal versican expression in the local metastases was 
statistically significantly more common than that in the primary tumors (Wilcoxon’s 
nonparametric test for two related samples, p=0.018). A high percentage of strong versican 
staining was also more common in less advanced tumors (SI-II vs. SIII-IV; χ2 test for 
independence, p<0.001) as well as in oropharyngeal tumors (χ2 test for independence, 
p=0.013). 
 
 
5.2.5. Interrelations between variables 
 
A high iNOS score was significantly associated with a high nuclear p53 expression index (χ2 
test for independence, p=0.006) and positive cytoplasmic p53 expression (χ2 test for 
independence, p=0.025). Nuclear p53 overexpression (index>240) or cytoplasmic p53 
expression was not related to either membranous catenin expression (α-, β-, or γ-catenin) 
or nuclear β-catenin expression. No association was seen between versican expression 
and p53, catenins, or any other tested variable.  
 
 
5.3. Disease-specific survival (DSS) 
 
Complete follow-up data were available for the whole cohort (n=138). The median follow-up 
time was 20 months (range 1-332; 95% CI 11-29). Of the 138 patients, 45 (33%) remained 
free of the disease during the follow-up. Forty-two (30%) patients did not achieve complete  
 






























